|
시장보고서
상품코드
1597053
북미의 가금용 백신 시장 예측(-2031년) 지역별 분석 - 유형별, 기술별, 투여형태별, 질환별, 투여경로별, 최종사용자별North America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User |
||||||
북미 가금용 백신 시장은 2023년에 7억 204만 달러로, 2031년까지는 13억 2,726만 달러에 이를 것으로 예측되며, 2023년부터 2031년까지의 CAGR은 8.3%를 나타낼 것으로 예측됩니다.
가금질병의 유행이 북미의 가금용 백신 시장을 활성화
가금류 생산은 계란과 고기를 통해 다양한 유형의 동물성 단백질을 생산합니다. 가금 생산량이 증가함에 따라, 특히 개발도상국에서는 막대한 경제적 손실을 초래할 수 있는 '가금병'과 같은 일부 인수 공통 감염에 걸릴 가능성이 높아집니다. 예를 들어, 닭은 박테리아, 바이러스, 기생충, 곰팡이 감염에 걸리기 쉽습니다. 이러한 바이러스 감염은 뉴캐슬병, 조류 인플루엔자, 전염성 활액포병 및 기타 가금류 질병을 유발할 수 있습니다.
가금병은 병아리 사망의 주요 원인이며 닭의 가축 생산성 저하로 이어집니다. 짐승 공통 감염을 확산시키고 포유류에 심각한 건강 위험을 초래하기 때문에 농부는 전 세계에서 막대한 경제적 손실에 직면하고 있습니다. 예를 들어, 가금 콕시듐증은 세계에서 가장 흔한 질병 중 하나이며 사망률과 체중 감소, 예방 및 치료 관리와 관련된 추가 비용과 관련된 엄청난 손실로 이어집니다. DSM 웹사이트에 따르면 세계 농부들은 닭과 조류의 콕시듐증으로 연간 30억 달러의 경제적 손실에 직면하고 있습니다. 뉴캐슬병은 또한 가금제품을 수출하는 개발도상국의 농가에게 막대한 생산손실을 초래하는 경제적으로 돈이 많이 드는 질병으로 보입니다.
따라서 막대한 경제적 손실을 초래하는 가금병의 유행 증가는 가금용 백신접종 수요를 끌어올려 시장을 견인하고 있습니다.
북미 가금류 백신 시장 개요
북미는 가금용 백신 시장의 주요 점유율을 차지하고 있습니다. 있기 때문에 이러한 사실은 예측 기간 동안이 지역 시장 성장에 영향을 미치는 중요한 요소 중 하나입니다.
북미 가금용 백신 시장 수익과 2031년까지 예측(금액)
북미 가금류 백신 시장 세분화
북미 가금류 백신 시장은 유형, 기술, 투여 형태, 질환, 투여 경로, 최종 사용자, 국가로 분류됩니다.
유형별로 북미의 가금류 백신 시장은 육계와 레이어로 2분화됩니다.
기술 측면에서 북미의 가금류 백신 시장은 약독생 백신, 불활화 백신, 재조합 백신으로 분류됩니다.
투여 형태별로 북미 가금류 백신 시장은 액체 백신, 동결건조 백신, 분말/분체 백신으로 구분됩니다.
질병별로, 북미의 가금류 백신 시장은 조류 인플루엔자, 전염성 기관지염, 말렉병, 조류 살모넬라증, 전염성 활액포염(IBD), 뉴캐슬병, 기타로 구분됩니다. 조류독감 부문이 2023년에 가장 큰 시장 점유율을 차지했습니다.
투여 경로의 관점에서 북미의 가금류 백신 시장은 식수(D/W), 근육내(I/M), 피하(I/S), 기타로 분류됩니다. 식수 부문이 2023년에 가장 큰 시장 점유율을 차지했습니다.
최종사용자에 따라 북미의 가금용 백신 시장은 양계장·부화장, 동물병원, 가금용 백신접종시설·클리닉으로 구분됩니다. 했습니다.
국가별로 북미의 가금류 백신 시장은 미국, 캐나다, 멕시코로 구분됩니다.
Starkey Laboratories Inc., Audina Hearing Instruments Inc., Sebotek Hearing Systems LLC, Earlens Corp., GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, Amplifon Hearing Health Care Corp. 는 가금용 백신 시장에서 사업을 전개하는 주요 기업입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
제4장 북미의 가금용 백신 시장 : 주요 시장 역학
- 시장 성장 촉진요인
- 가금질환의 유병률 상승
- 가금산업의 성장
- 시장 성장 억제요인
- 예방접종 실패와 부적절한 취급
- 시장 기회
- 대량 백신접종에 대한 정부의 지원과 혁신적인 체계
- 향후의 동향
- 벡터 백신 및 혼합 백신의 진보
- 성장 촉진요인과 억제요인의 영향
제5장 북미의 가금용 백신 시장 분석
- 가금용 백신 시장 수익, 2023-2031년
제6장 북미의 가금용 백신 시장 분석 : 유형별
- 육계
- 레이어
제7장 북미의 가금용 백신 시장 분석 : 기술별
- 생백신
- 불활성화 백신
- 재조합 백신
제8장 북미의 가금용 백신 시장 분석 : 투여 형태별
- 액체 백신
- 프리즈 드라이 백신
- 분말 백신
제9장 북미의 가금용 백신 시장 분석 : 질환별
- 조류 인플루엔자
- 살모넬라증
- 말렉병
- 감염성 기관지염(IB)
- 감염성 활액포염(IBD)
- 뉴캐슬병
- 기타
제10장 북미의 가금용 백신 시장 분석 : 투여 경로별
- 식수(D/W)
- 근육내(I/M)
- 피하 투여(S/C)
- 기타
제11장 북미의 가금용 백신 시장 분석 : 최종 사용자별
- 양계장
- 동물병원
- 가금용 백신 접종 센터·진료소
제12장 북미 가금용 백신 시장 : 국가별 분석
- 북미 시장 개요
- 미국
- 캐나다
- 멕시코
제13장 업계 정세
- 가금용 백신 시장에서의 성장 전략
- 유기적 발전
- 무기적 발전
제14장 기업 프로파일
- Boehringer Ingelheim International GmbH
- Zoetis Inc
- Phibro Animal Health Corp
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Inc
- Merck KGaA
- Ceva
- Vaccinova AB
제15장 부록
JHS 24.12.04The North America poultry vaccines market was valued at US$ 702.04 million in 2023 and is expected to reach US$ 1,327.26 million by 2031; it is estimated to record a CAGR of 8.3% from 2023 to 2031.
Rising Prevalence of Poultry Diseases Fuels North America Poultry Vaccines Market
Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as "Fowl disease" that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle Disease, Avian Influenza, Infectious Bursal Disease, and other diseases in other poultry animals.
Poultry diseases are a major cause of death of chicks and also lead to reduced livestock productivity of chickens. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products.
Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.
North America Poultry Vaccines Market Overview
North America accounts major share for poultry vaccines market. Among the North America regional market, US accounts maximum share due to presence of top companies in the country and well-established centers providing vaccination services. Such aforementioned facts are one of the key factors that influence market growth in the region for the forecast period.
North America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)
North America Poultry Vaccines Market Segmentation
The North America poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.
Based on type, the North America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.
In terms of technology, the North America poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.
By dosage form, the North America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.
Based on disease, the North America poultry vaccines market is segmented into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.
In terms of route of administration, the North America poultry vaccines market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.
Based on end user, the North America poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.
By country, the North America poultry vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry vaccines market share in 2023.
Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America poultry vaccines market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
4. North America Poultry Vaccines Market - Key Market Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Prevalence of Poultry Diseases
- 4.1.2 Growing Poultry Industry
- 4.2 Market Restraints
- 4.2.1 Vaccination Failure and Improper Handling
- 4.3 Market Opportunities
- 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
- 4.4 Future Trends
- 4.4.1 Advancements in Vectored and Combination Vaccines
- 4.5 Impact of Drivers and Restraints:
5. North America Poultry Vaccines Market Analysis
- 5.1 Poultry Vaccines Market Revenue (US$ Million), 2023-2031
6. North America Poultry Vaccines Market Analysis - by Type
- 6.1 Overview
- 6.2 Broiler
- 6.2.1 Overview
- 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 6.3 Layer
- 6.3.1 Overview
- 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7. North America Poultry Vaccines Market Analysis - by Technology
- 7.1 Overview
- 7.2 Live Attenuated Vaccines
- 7.2.1 Overview
- 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Inactivated Vaccines
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Recombinant Vaccines
- 7.4.1 Overview
- 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8. North America Poultry Vaccines Market Analysis - by Dosage Form
- 8.1 Overview
- 8.2 Liquid Vaccines
- 8.2.1 Overview
- 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Freeze-Dried Vaccines
- 8.3.1 Overview
- 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 8.4 Dust/Powdered Vaccines
- 8.4.1 Overview
- 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Poultry Vaccines Market Analysis - by Disease
- 9.1 Overview
- 9.2 Avian Influenza
- 9.2.1 Overview
- 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3 Salmonellosis
- 9.3.1 Overview
- 9.3.2 Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4 Marek's Disease
- 9.4.1 Overview
- 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 9.5 Infectious Bronchitis (IB)
- 9.5.1 Overview
- 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 9.6 Infectious Bursal Disease (IBD)
- 9.6.1 Overview
- 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 9.7 Newcastle Disease
- 9.7.1 Overview
- 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10. North America Poultry Vaccines Market Analysis - by Route of Administration
- 10.1 Overview
- 10.2 Drinking Water (D/W)
- 10.2.1 Overview
- 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3 Intramuscular (I/M)
- 10.3.1 Overview
- 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4 Subcutaneous (S/C)
- 10.4.1 Overview
- 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11. North America Poultry Vaccines Market Analysis - by End User
- 11.1 Overview
- 11.2 Poultry Farms
- 11.2.1 Overview
- 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 11.3 Veterinary Hospitals
- 11.3.1 Overview
- 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 11.4 Poultry Vaccination Centers and Clinics
- 11.4.1 Overview
- 11.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
12. North America Poultry Vaccines Market - Country Analysis
- 12.1 North America Market Overview
- 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
- 12.1.1.1 United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 12.1.1.1.1 Overview
- 12.1.1.1.2 United States: Poultry Vaccines Market Breakdown by Type
- 12.1.1.1.3 United States: Poultry Vaccines Market Breakdown by Technology
- 12.1.1.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
- 12.1.1.1.5 United States: Poultry Vaccines Market Breakdown by Disease
- 12.1.1.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
- 12.1.1.1.7 United States: Poultry Vaccines Market Breakdown by End User
- 12.1.1.2 Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 12.1.1.2.1 Overview
- 12.1.1.2.2 Canada: Poultry Vaccines Market Breakdown by Type
- 12.1.1.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
- 12.1.1.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
- 12.1.1.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
- 12.1.1.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
- 12.1.1.2.7 Canada: Poultry Vaccines Market Breakdown by End User
- 12.1.1.3 Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 12.1.1.3.1 Overview
- 12.1.1.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
- 12.1.1.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
- 12.1.1.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
- 12.1.1.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
- 12.1.1.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
- 12.1.1.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
- 12.1.1.1 United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
- 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
13. Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies in the Poultry Vaccines Market
- 13.3 Organic Developments
- 13.3.1 Overview
- 13.1 Inorganic Developments
- 13.1.1 Overview
14. Company Profiles
- 14.1 Boehringer Ingelheim International GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Zoetis Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Phibro Animal Health Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Dechra Pharmaceuticals PLC
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Elanco Animal Health Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Ceva
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 Vaccinova AB
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms
